Introduction: Who Should Seek Diagnostic Testing
Every pregnant woman receives routine checks throughout pregnancy, but certain women need closer attention when it comes to screening for conditions like preeclampsia and eclampsia. If you are pregnant and have never given birth before, are carrying twins or other multiples, or have pre-existing health conditions such as high blood pressure, diabetes, or kidney disease, your healthcare provider will monitor you more carefully.[1] Women who are teenagers, over 35 years old, or have a personal or family history of preeclampsia also need heightened awareness and regular testing.[1]
Most women who develop eclampsia have a preceding condition called preeclampsia, which means they develop high blood pressure and protein in their urine after the 20th week of pregnancy. However, in some cases, eclampsia can appear suddenly without any prior warning signs, which is why the condition was named after the Greek word for “lightning.”[3] This unpredictable nature makes regular prenatal appointments absolutely essential, even when you feel perfectly fine. Blood pressure and urine checks at each visit help catch early signs before they progress to something more dangerous.[6]
Eclampsia typically occurs during the final three months of pregnancy, but it can also develop during labor or within six weeks after delivery. The highest risk period is actually in the first 48 hours after giving birth.[2] Because of this, monitoring doesn’t stop once your baby is born. Healthcare providers continue to watch for warning signs in the postpartum period, especially if you had preeclampsia during your pregnancy.
Understanding your personal risk factors helps you and your healthcare team decide how frequently you need testing and what type of monitoring makes sense for your situation. Women at high risk may be prescribed low-dose aspirin starting between the 12th and 28th week of pregnancy, ideally before 16 weeks, to help reduce the chances of developing preeclampsia in the first place.[3] This preventive approach shows how early identification of risk can lead to protective measures before serious complications arise.
Classic Diagnostic Methods for Eclampsia
Diagnosing eclampsia starts with recognizing the hallmark feature: seizures in a pregnant or recently pregnant woman. When a woman experiences a seizure during pregnancy or shortly after delivery, and there’s no other known reason for it—such as epilepsy or a stroke—doctors diagnose eclampsia.[9] The seizure itself is both a symptom and a defining diagnostic feature. These seizures typically last about one to two minutes and involve facial twitching, body-wide muscle contractions and relaxations, foaming at the mouth, and a brief period of unconsciousness afterward.[1]
The diagnostic process actually begins much earlier, with routine monitoring for preeclampsia during prenatal visits. At each appointment, healthcare providers measure your blood pressure. A reading of 140/90 mm Hg or higher on two separate occasions, at least four hours apart, after the 20th week of pregnancy signals potential preeclampsia.[4] It’s important to understand that you likely won’t feel any different when your blood pressure is elevated, which is exactly why these routine checks matter so much. High blood pressure is often called a “silent” condition because it causes no noticeable symptoms until complications develop.
Urine tests are another fundamental diagnostic tool. During prenatal visits, healthcare providers check your urine for protein, a condition called proteinuria. When your kidneys are under stress from high blood pressure, they may allow protein to leak into the urine. The presence of large amounts of protein, combined with high blood pressure, points to preeclampsia.[9] Your provider may collect a single urine sample at your appointment or ask you to collect all your urine over a 24-hour period to measure total protein levels more accurately.
Blood tests help doctors understand how preeclampsia is affecting your body and whether it’s progressing toward more serious complications. These tests examine several key indicators. Your blood platelet count shows whether your blood is clotting properly—low platelets suggest your condition is worsening.[9] Liver enzyme tests reveal whether your liver is under stress. Kidney function tests, including creatinine levels, show how well your kidneys are filtering waste products from your blood. When creatinine levels rise abnormally high, it can be a warning sign of kidney damage or failure.[9]
Beyond laboratory tests, healthcare providers perform physical examinations to check for visible signs of preeclampsia that might progress to eclampsia. They look for sudden, excessive swelling in your face, hands, and feet. While some swelling is normal in pregnancy, rapid weight gain and pronounced swelling in unusual areas can indicate fluid retention caused by preeclampsia.[6] Your provider will also ask about symptoms you might be experiencing, such as persistent headaches, vision changes like spots or flashing lights, nausea and vomiting, and pain just below your ribs on the right side.
Fetal monitoring is an essential part of the diagnostic picture. Doctors use ultrasound and other monitoring techniques to check how your baby is tolerating the pregnancy. They measure the baby’s heart rate, movement, growth, and the amount of amniotic fluid surrounding the baby.[9] Preeclampsia can affect blood flow through the placenta, which may slow your baby’s growth or cause other complications. Regular fetal assessments help doctors decide whether it’s safer to continue the pregnancy with close monitoring or to deliver the baby early.
In more complex cases, especially when neurological symptoms are present, doctors may order imaging studies of the brain. A computed tomography (CT) scan or magnetic resonance imaging (MRI) can help rule out other causes of seizures, such as bleeding in the brain or a stroke.[4] These scans aren’t routine for every case of suspected eclampsia, but they become important when doctors need to understand whether there are additional complications or when the diagnosis isn’t entirely clear.
One challenge in diagnosing preeclampsia and eclampsia is that the condition can sometimes appear without the typical warning signs. In some women, eclampsia develops even without a prior diagnosis of preeclampsia or without protein in the urine.[2] This is why healthcare providers pay attention to the full clinical picture—your symptoms, your risk factors, your test results, and how you’re feeling—rather than relying on just one or two pieces of information.
After a seizure occurs, the diagnosis of eclampsia is made based on the presence of the seizure itself in the context of pregnancy or the postpartum period, especially if preeclampsia was already known or suspected.[9] However, doctors must still rule out other possible causes of seizures. They will consider whether you have a history of epilepsy, whether you might have experienced a stroke, or whether another medical condition could explain the seizure. Blood tests, imaging, and a thorough review of your medical history help clarify the picture.
Home blood pressure monitoring has become an increasingly valuable tool for women at risk for preeclampsia. Some healthcare providers will ask you to check your blood pressure at home between appointments, especially if you’ve had elevated readings or if you have risk factors. This provides a more complete picture of your blood pressure patterns throughout the day and can catch dangerous spikes that might occur between scheduled visits.[5] If your provider recommends home monitoring, make sure you’re using the device correctly and understand when to report abnormal readings.
Diagnostics for Clinical Trial Qualification
When researchers study eclampsia and preeclampsia in clinical trials, they use specific diagnostic criteria to decide who can participate. These criteria ensure that all participants truly have the condition being studied and that the results of the trial will be meaningful and reliable. Clinical trials for eclampsia typically focus on testing new treatments or comparing different approaches to managing the condition, so accurate diagnosis is the foundation of the entire study.
For a woman to be enrolled in a clinical trial related to eclampsia, she must meet the diagnostic definition: new-onset seizures during pregnancy or in the postpartum period, occurring in the absence of other neurological conditions, and typically in the setting of preeclampsia.[2] Trial coordinators will review medical records, confirm that seizures occurred, and verify that other potential causes have been ruled out. They may require documentation of blood pressure readings, urine protein levels, and blood test results before enrolling a participant.
For preeclampsia trials—which aim to prevent progression to eclampsia—enrollment criteria include documented high blood pressure (systolic pressure of 140 mm Hg or higher, or diastolic pressure of 90 mm Hg or higher) after 20 weeks of pregnancy, along with either proteinuria or other signs of organ damage.[4] Organ damage can include signs such as elevated liver enzymes, low platelet counts, kidney problems, fluid in the lungs, or new neurological symptoms like persistent headaches or vision problems. Clinical trials often define exactly how these measurements must be taken, how many times they need to be repeated, and what thresholds must be met.
Laboratory testing standards in clinical trials are more rigorous than in regular clinical care. Researchers may specify the exact laboratory methods used to measure protein in urine, the timing of blood draws, and the specific blood tests that must be performed. For example, some trials may require that blood platelet counts fall below a certain level, or that liver enzyme levels exceed a certain threshold, before a woman is considered eligible.[4] These strict standards help ensure that all trial participants have similar disease severity, making it easier to compare treatment outcomes.
Fetal assessment is another key component of diagnostic criteria in clinical trials. Researchers may use ultrasound measurements to assess fetal growth, amniotic fluid volume, and blood flow through the umbilical cord and placenta. Women whose babies show signs of growth restriction or poor placental function may be included in trials testing interventions designed to improve outcomes for both mothers and babies.[4] The timing and frequency of these ultrasound exams are carefully defined in the trial protocol.
Clinical trials often categorize preeclampsia into mild and severe forms based on specific diagnostic criteria. Severe preeclampsia may be defined by very high blood pressure (systolic pressure of 160 mm Hg or higher, or diastolic pressure of 110 mm Hg or higher), significantly elevated protein levels in urine, low platelet counts, elevated liver enzymes, kidney problems, or symptoms such as severe headaches or vision changes.[4] Women with severe features may be enrolled in different trials than those with milder disease, since they may need different interventions or have different risks.
Exclusion criteria in clinical trials are just as important as inclusion criteria. Researchers need to make sure that participants don’t have other conditions that could confuse the results. For example, women with pre-existing high blood pressure before pregnancy, chronic kidney disease, or a history of seizures from epilepsy might be excluded from some eclampsia trials because their underlying conditions could affect their response to treatment or make it harder to determine whether the trial intervention is working.[4]
The timing of diagnosis matters greatly in clinical trials. Some trials may focus on early-onset preeclampsia (before 34 weeks of pregnancy), while others may study late-onset disease (after 34 weeks). Researchers may also distinguish between preeclampsia that develops during pregnancy and postpartum preeclampsia, which appears only after delivery.[2] The gestational age at diagnosis—how far along the pregnancy is—becomes a key piece of data that helps researchers understand who benefits most from particular treatments.
Postpartum monitoring is another diagnostic consideration in clinical trials. Since eclampsia can occur up to six weeks after delivery, some trials continue to track participants after birth. Researchers may require regular blood pressure checks, repeat blood tests, and continued symptom monitoring during the postpartum period.[1] This helps capture cases of postpartum eclampsia and allows researchers to study whether interventions given during pregnancy have lasting protective effects.
In summary, diagnostic testing for clinical trial enrollment is more standardized, detailed, and rigorous than routine clinical diagnosis. These strict protocols ensure that research findings are accurate, reliable, and can be applied to real-world care. If you’re considering participating in a clinical trial for eclampsia or preeclampsia, the research team will explain exactly which diagnostic tests you’ll need and how the results will be used to determine your eligibility.


